Prokein Benjamin, Dau Michael, Frerich Bernhard
Klinik und Poliklinik für Mund‑, Kiefer- und Plastische Gesichtschirurgie, Universitätsmedizin Rostock, Schillingallee 35, 18057, Rostock, Deutschland.
HNO. 2024 Dec;72(12):893-899. doi: 10.1007/s00106-024-01520-0. Epub 2024 Nov 6.
After the first appearance of COVID-19 cases, the virus spread worldwide within a few months. This led to a decrease in medical consultations. The present study investigates whether this effect had an impact on the diagnosis and treatment of head and neck cancer during the period from 2018 to 2022.
Data from the clinical cancer registration center (KKR) of Mecklenburg-Vorpommern from the 2020-2022 period were compared to those from the two previous years (2018, 2019). Demographic data, case numbers, diagnosis data, International Classification of Diseases (ICD) codes, and TNM classifications were recorded. COVID-19 case numbers were obtained from the Robert Koch Institute (RKI). Data were analyzed using the Mann-Whitney U test and Pearson's correlation.
A total of 2332 patient cases could be included in this study. During the lockdown there was neither a significant reduction in tumor diagnoses registered at the KKR nor a correlation between COVID-19 case numbers and tumor diagnoses. Significant differences were found in terms of T category in the year 2022 compared to the pre-COVID years 2018 and 2019. Furthermore, there was a shift in the relative frequencies of some ICD-10 codes.
During the COVID-19 pandemic, no significant differences in tumor diagnoses were observed upon comparing the years 2018 to 2022. Contrary to the expectation of a decrease in case numbers during the pandemic due to the lockdown with an increase in tumor stages, a reduction of the T category could be found in 2022, and a shift in the relative frequencies of some ICD-10 codes in the pandemic period was observed.
新冠病毒疾病（COVID-19）病例首次出现后，该病毒在数月内蔓延至全球。这导致了医疗咨询量的下降。本研究调查了这种影响在2018年至2022年期间对头颈部癌症的诊断和治疗是否产生了影响。
将梅克伦堡-前波美拉尼亚临床癌症登记中心（KKR）2020 - 2022年期间的数据与前两年（2018年、2019年）的数据进行比较。记录了人口统计学数据、病例数、诊断数据、国际疾病分类（ICD）编码和TNM分类。COVID-19病例数来自罗伯特·科赫研究所（RKI）。使用曼-惠特尼U检验和皮尔逊相关性分析数据。
本研究共纳入2332例患者病例。在封锁期间，KKR登记的肿瘤诊断数量既没有显著减少，COVID-19病例数与肿瘤诊断之间也没有相关性。与2018年和2019年新冠疫情前的年份相比，2022年在T类别方面发现了显著差异。此外，一些ICD - 10编码的相对频率发生了变化。
在COVID-19大流行期间，比较2018年至2022年，未观察到肿瘤诊断有显著差异。与因封锁预计大流行期间病例数减少且肿瘤分期增加相反，2022年发现T类别有所减少，并且观察到在大流行期间一些ICD - 10编码的相对频率发生了变化。
